- Home
- KFS vs VYGR Comparison
KFS vs VYGR Comparison
Compare KFS & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFS
- VYGR
- Stock Information
- Founded
- KFS 1989
- VYGR 2013
- Country
- KFS United States
- VYGR United States
- Employees
- KFS N/A
- VYGR N/A
- Industry
- KFS Property-Casualty Insurers
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- KFS Finance
- VYGR Health Care
- Exchange
- KFS Nasdaq
- VYGR Nasdaq
- Market Cap
- KFS 223.3M
- VYGR 235.4M
- IPO Year
- KFS 1996
- VYGR 2015
- Fundamental
- Price
- KFS $7.66
- VYGR $4.22
- Analyst Decision
- KFS
- VYGR Strong Buy
- Analyst Count
- KFS 0
- VYGR 9
- Target Price
- KFS N/A
- VYGR $15.53
- AVG Volume (30 Days)
- KFS 22.3K
- VYGR 374.5K
- Earning Date
- KFS 03-04-2025
- VYGR 03-03-2025
- Dividend Yield
- KFS N/A
- VYGR N/A
- EPS Growth
- KFS N/A
- VYGR N/A
- EPS
- KFS N/A
- VYGR 0.47
- Revenue
- KFS $108,627,000.00
- VYGR $163,784,000.00
- Revenue This Year
- KFS N/A
- VYGR N/A
- Revenue Next Year
- KFS N/A
- VYGR N/A
- P/E Ratio
- KFS N/A
- VYGR $9.13
- Revenue Growth
- KFS 2.02
- VYGR 3.40
- 52 Week Low
- KFS $7.60
- VYGR $4.00
- 52 Week High
- KFS $9.58
- VYGR $10.66
- Technical
- Relative Strength Index (RSI)
- KFS 33.79
- VYGR 29.98
- Support Level
- KFS $7.73
- VYGR $4.20
- Resistance Level
- KFS $8.00
- VYGR $4.60
- Average True Range (ATR)
- KFS 0.18
- VYGR 0.31
- MACD
- KFS -0.02
- VYGR -0.08
- Stochastic Oscillator
- KFS 10.17
- VYGR 12.36
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.